Gabapentin (Neurontin) 2000 ng cut-off Single Panel Dip Card Drug Test Free Shipping 25/Box
Gabapentin (Neurontin) Single Panel Dip Card Drug Test 25/Box
- Detects Metabolites of Gabapentin/Neurontin (GPT), Pregabalin, and Vigabatrin
- Low Price Guarantee - Wholesale Bulk Pricing
- Single Drug Test
- Results within 5 Minutes
- Great for Home and Office
- Easy to Read Results
- 12-18 month expiration date on all drug test kits
|Gabapentin (Neurontin)||2,000 ng/mL||HDGP-114||DIP CARD||1-PANEL||GAB|
Long considered safe and non-addictive, gabapentin is increasingly showing up in the bodies of people who overdose on heroin and prescription opioids. Researchers are now finding that the alternative painkiller has become a drug of abuse. Doctors who are cutting back on prescribing opioids increasingly are opting for gabapentin, which is considered a safer, non-narcotic drug recommended by the Centers for Disease Control. By doing so, they may be putting their opioid-using patients at even greater risk. Recently, gabapentin has started showing up in a substantial number of overdose deaths in hard-hit Appalachian states. The neuropathic (nerve-related) pain reliever was involved in more than a third of Kentucky overdose deaths last year.
Drug users say gabapentin pills, known as “johnnies” or “gabbies,” which often sell for less than a dollar each, enhance the euphoric effects of heroin and when taken alone in high doses can produce a marijuana-like high. Medical researchers stress that more study is needed to determine the role gabapentin may have played in recent overdose deaths. However, a study of heroin users in England and Wales published last fall concluded that combining opioids and gabapentin “potentially increases the risk of acute overdose death” by hampering breathing and reversing users’ tolerance to heroin and other powerful opioids.
Kentucky last year classified gabapentin as a controlled substance, making it harder for doctors to prescribe it in copious quantities and for long durations. The new classification also allows police to arrest anyone who illicitly sells the drug, although the state’s drug control chief, Van Ingram, said that was not the intent of the new law. In the last two years, Illinois, Ohio, Massachusetts, Minnesota, Tennessee, Virginia and Wyoming also have moved to control the flow of gabapentin by requiring doctors and pharmacists to check a prescription drug database before prescribing it to patients to make sure they aren’t already receiving gabapentin, or some other medication that interacts with it, from another physician.